Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Alfredo Domínguez-Muñoz, Roberto Dávila-Perez, Emilio Fernández-Portilla, Israel Parra-Ortega, Alfonso Reyes-López, Eduardo Bracho-Blanchet
Introduction: Procalcitonin (PCT) has been studied for early identification of Ischemia and/or Necrosis (I/N) in children with Intestinal Obstruction (IO) secondary to Adhesive Small Bowel Obstruction (ASBO). However, the causes of IO in children are numerous.
Purpose: To correlate the level of PCT with the presence of I/N.
Results: Fifty-seven patients were analyzed. The incidence of I/N was 36%. PCT median was statistically higher in patients with I/N compared to those patients with normal intestine: 4.13 (13.9) vs. 0.11 (0.28) ng/ml, p=<0.001. A PCT threshold >1.17 ng/ml for predicting I/N yielded a sensitivity of 90%, a specificity of 97%, a Positive Predictive Value (PPV) of 95%, a Negative Predictive Value (NPV) of 94%, p=<0.001, Relative Risk (RR) 17.57 (95% CI, 4.54-67.90). Similarly, a PCT threshold >1.41 ng/ml for predicting intestinal necrosis yielded a sensitivity of 92%, a specificity of 88%, a PPV of 72%, a NPV of 97%, p=<0.001, RR 28.16 (95% CI, 3.98-119.12).
Conclusion: This study corroborates the association of PCT with IN in children with IO and expands the evidence of its use in this field. Similarly, suggests a PCT threshold >1.17 ng/ml and >1.41 for predicting IN and intestinal necrosis respectively.